Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene in Postmenopausal Asian Women
NCT00384072Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Bazedoxifene 20 mg with Placebo (2 arms). Primary endpoint: Percent change from baseline in lumbar spine bone mineral density at 6 months. Started May 2006; status: completed.
02
Drugs
bazedoxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00384072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384072.